COVID-19 and the human body: nicotine as a “controller” of the molecular expression of ACE-2
Nicotine is a protective shield against the insurgence of severe symptoms of COVID-19. This is what emerged with the new study by CoEHAR
CoEHAR’s study confirms beneficial effects of ecig on copd smokers
CoEHAR's researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting
Expert Panel to Discuss Diversity and Harm Reduction in Global Tobacco Control Policy Virtual Webinar Sessions Sept.30 and Oct.1
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
Gtfn 2020: Sustainability and Innovation are crucially for the future of Tobacco Harm Reduction
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
CoEHAR research set new guidelines for the dosage of nicotine in liquids
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
Italy: Annual Report of Italian Customs and Monopoly reveals a drastic drop in cigarette sales
Presented in Italy the “Blue Book”, the document containing the results achieved last year by the Italian Customs and Monopoly Agency. The most impressive result was the contraction of 6.80% in…
A study by CoEHAR reveals antibacterial properties in e-cigarette liquids
According to a study lead by CoEHAR of the University of Catania, the e-liquids used in electronic cigarettes have antibacterial properties effective on different pathogens
Quit Strong: New Zealand bets on vaping to quit smoking
QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking
Do You really know what Tobacco Harm Reduction is?
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
- Go to the previous page
- 1
- …
- 9
- 10
- 11
- 12